LAVA-1433

N/A

Report date: 2024/03/11 16:06:08

Base Information

Drug NameLAVA-1433

Drug Alias NameLAVA-1433

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionImmunologic cytotoxicityIntraepithelial lymphocyte agonists

TargetsUpdating

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesLava Therapeutics NV

China Registration ClassN/A

Develop Information

Active CompaniesLava Therapeutics NV

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A